Induction of A Dose–Related Increase in Sulfobromophthalein Uptake Velocity in Freshly Isolated Rat Hepatocytes by Phenobarbital
Open Access
- 1 October 1994
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 20 (4) , 1078-1085
- https://doi.org/10.1002/hep.1840200441
Abstract
To determine whether phenobarbital affects hepatocellular bilirubin/sulfobromophthalein uptake mechanism, we administered it to male Sprague–Dawley rats, body weight 175 ± 25 gm, at doses of 1 to 75 mg/kg body wt/day for 7 days. Control rats were given an equivalent volume of physiological saline solution. On day 8, hepatocytes were isolated by means of collagenase perfusion, suspended in Hanks' solution without albumin and incubated with high specific activity (3 Ci/mmol) [35S]sulfobromophthalein, which was synthesized in our laboratory and purified by means of a new reverse–phase high–pressure liquid chromatography procedure. The initial uptake rate of sulfobromophthalein was determined at sulfobromophthalein concentrations of 1 to 50 μmol/L with a rapid filtration technique. The maximum uptake velocity and Michaelis constant for sulfobromophthalein uptake at each phenobarbital dose were determined by means of a computer analysis. In control studies, maximum uptake and Michaelis constant were 48.0 ± 16.7 (mean ± S.D.) pmol/50,000 cells/min and 22 ± 4 μmol/L, respectively. Maximum uptake velocity increased linearly with the log of the phenobarbital dose (r = 0.98, p < 0.01), the increase achieving statistical significance at a dose of 3 mg/kg/day. Michaelis constant, however, was essentially unchanged at phenobarbital doses of 50 mg/kg/day or less. The maximal observed increase in maximum uptake velocity of sulfobromophthalein (to 619% of control values) was appreciably greater than the maximal increase in UDP–glucuronyltransferase activity (200% of control) or immunoreactive ligandin concentrations (260% of control) seen in earlier studies, suggesting a direct effect on the plasma membrane transport mechanism. (Hepatology 1994;20:1078-1085).Keywords
This publication has 45 references indexed in Scilit:
- Phenobarbital does not increase early labeling of bilirubin from 4-[14C]-δ-aminolevulinic acid in man and ratHepatology, 1991
- Hepatocellular uptake of sulfobromophthalein and bilirubin is selectively inhibited by an antibody to the liver plasma membrane sulfobromophthalein/bilirubin binding protein.Journal of Clinical Investigation, 1986
- Ligandin heterogeneity: Evidence that the two non-identical subunits are the monomers of two distinct proteinsBiochimica et Biophysica Acta (BBA) - Protein Structure, 1977
- Hepatic organic anion uptake in the rat.Journal of Clinical Investigation, 1975
- Failure qf phenobarbital to increase bilirubin production in the ratBiochemical Pharmacology, 1974
- Augmentation of Bilirubin UDP Glucuronyltransferase Activity in Rat Liver Homogenates by GlutethimideExperimental Biology and Medicine, 1972
- Immunological Studies of Y Protein. A MAJOR CYTOPLASMIC ORGANIC ANION-BINDING PROTEIN IN RAT LIVERJournal of Clinical Investigation, 1972
- Studies of Y and Z, two hepatic cytoplasmic organic anion-binding proteins: effect of drugs, chemicals, hormones, and cholestasisJournal of Clinical Investigation, 1971
- Heme and methemoglobin: Naturally occurring repressors of microsomal cytochromeBiochemical and Biophysical Research Communications, 1968
- Enhanced formation of rapidly labeled bilirubin by phenobarbital: Hepatic microsomal cytochromes as a possible sourceBiochemical and Biophysical Research Communications, 1966